SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (330)2/3/2002 3:25:13 PM
From: keokalani'nui   of 1022
 
One would not know in general, only if drug's sponsor disclosed it. Yet I think every company with a Mab of any type, chimeric, humanized, or fully human (mouse or phage) in clinical development would disclose, or has disclosed, its origination, since this would be of interest to many for many reasons. There have been plenty of review articles describing all Mabs in development, get your hands on one of those and track 'em down. You can pretty much figure that anyone claiming a fully human Mab who does not have a license from abgx, medx, deltagen or genmab (or Charles R.?) is using phage.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext